NewAmsterdam Pharma Company
NAMS
#4245
Rank
โ‚ฌ1.93 B
Marketcap
20,99ย โ‚ฌ
Share price
3.95%
Change (1 day)
120.15%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ54.94 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are โ‚ฌ54.94 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2021 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ48.43 M328.14%
2021-12-31โ‚ฌ11.31 M-28.19%
2020-12-31โ‚ฌ15.75 M